• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习算法辅助诊断慢性丙型肝炎患者的肝硬化:一种新型非侵入性方法。

Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive Approach.

作者信息

Dirican Emre, Bal Tayibe, Onlen Yusuf, Sarigul Figen, User Ulku, Sari Nagehan Didem, Kurtaran Behice, Senates Ebubekir, Gunduz Alper, Zerdali Esra, Karsen Hasan, Batirel Ayse, Karaali Ridvan, Guner Hatice Rahmet, Yamazhan Tansu, Kose Sukran, Erben Nurettin, Ince Nevin Koc, Koksal Iftihar, Oztoprak Nefise, Yoruk Gulsen, Komur Suheyla, Kaya Sibel Yildiz, Bozkurt Ilkay, Gunal Ozgur, Yildiz Ilknur Esen, Inan Dilara, Barut Sener, Namiduru Mustafa, Tosun Selma, Turker Kamuran, Sener Alper, Hizel Kenan, Baykam Nurcan, Duygu Fazilet, Bodur Hurrem, Can Guray, Gul Hanefi Cem, Tartar Ayse Sagmak, Celebi Guven, Sunnetcioglu Mahmut, Karabay Oguz, Kumbasar Karaosmanoglu Hayat, Sirmatel Fatma, Tabak Omer Fehmi

机构信息

Department of Biostatistics, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay, Turkey.

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Bolu Abant Izzet Baysal University, Bolu, Turkey.

出版信息

J Clin Lab Anal. 2025 Jun;39(12):e70054. doi: 10.1002/jcla.70054. Epub 2025 May 19.

DOI:10.1002/jcla.70054
PMID:40384539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12179807/
Abstract

AIM

This study aimed to determine the important features and cut-off values after demonstrating the detectability of cirrhosis using routine laboratory test results of chronic hepatitis C (CHC) patients in machine learning (ML) algorithms.

METHODS

This retrospective multicenter (37 referral centers) study included the data obtained from the Hepatitis C Turkey registry of 1164 patients with biopsy-proven CHC. Three different ML algorithms were used to classify the presence/absence of cirrhosis with the determined features.

RESULTS

The highest performance in the prediction of cirrhosis (Accuracy = 0.89, AUC = 0.87) was obtained from the Random Forest (RF) method. The five most important features that contributed to the classification were platelet, αlpha-feto protein (AFP), age, gamma-glutamyl transferase (GGT), and prothrombin time (PT). The cut-off values of these features were obtained as platelet < 182.000/mm, AFP > 5.49 ng/mL, age > 52 years, GGT > 39.9 U/L, and PT > 12.35 s. Using cut-off values, the risk coefficients were AOR = 4.82 for platelet, AOR = 3.49 for AFP, AOR = 4.32 for age, AOR = 3.04 for GGT, and AOR = 2.20 for PT.

CONCLUSION

These findings indicated that the RF-based ML algorithm could classify cirrhosis with high accuracy. Thus, crucial features and cut-off values for physicians in the detection of cirrhosis were determined. In addition, although AFP is not included in non-invasive indexes, it had a remarkable contribution in predicting cirrhosis.

TRIAL REGISTRATION

Clinicaltrials.gov identifier: NCT03145844.

摘要

目的

本研究旨在利用慢性丙型肝炎(CHC)患者的常规实验室检测结果,在机器学习(ML)算法中证明肝硬化的可检测性之后,确定其重要特征和临界值。

方法

这项回顾性多中心(37个转诊中心)研究纳入了从土耳其丙型肝炎登记处获得的1164例经活检证实为CHC患者的数据。使用三种不同的ML算法,根据确定的特征对肝硬化的存在与否进行分类。

结果

随机森林(RF)方法在肝硬化预测方面表现最佳(准确率=0.89,曲线下面积=0.87)。对分类有贡献的五个最重要特征是血小板、甲胎蛋白(AFP)、年龄、γ-谷氨酰转移酶(GGT)和凝血酶原时间(PT)。这些特征的临界值分别为血小板<182,000/mm、AFP>5.49 ng/mL、年龄>52岁、GGT>39.9 U/L和PT>12.35秒。使用临界值,血小板的风险系数比值比(AOR)=4.82,AFP的AOR=3.49,年龄的AOR=4.32,GGT的AOR=3.04,PT的AOR=2.20。

结论

这些发现表明,基于RF的ML算法能够高精度地对肝硬化进行分类。因此,确定了医生在检测肝硬化时的关键特征和临界值。此外,尽管AFP未包含在非侵入性指标中,但它在预测肝硬化方面有显著贡献。

试验注册

Clinicaltrials.gov标识符:NCT03145844。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da7/12179807/574957b1fa34/JCLA-39-e70054-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da7/12179807/a1ce9ccedc43/JCLA-39-e70054-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da7/12179807/3f9952e388f9/JCLA-39-e70054-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da7/12179807/a52229864b2c/JCLA-39-e70054-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da7/12179807/117f075daa82/JCLA-39-e70054-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da7/12179807/574957b1fa34/JCLA-39-e70054-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da7/12179807/a1ce9ccedc43/JCLA-39-e70054-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da7/12179807/3f9952e388f9/JCLA-39-e70054-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da7/12179807/a52229864b2c/JCLA-39-e70054-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da7/12179807/117f075daa82/JCLA-39-e70054-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da7/12179807/574957b1fa34/JCLA-39-e70054-g006.jpg

相似文献

1
Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive Approach.基于机器学习算法辅助诊断慢性丙型肝炎患者的肝硬化:一种新型非侵入性方法。
J Clin Lab Anal. 2025 Jun;39(12):e70054. doi: 10.1002/jcla.70054. Epub 2025 May 19.
2
Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.血小板计数、脾脏长度以及血小板计数与脾脏长度之比在慢性肝病或门静脉血栓形成患者食管静脉曲张诊断中的应用
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD008759. doi: 10.1002/14651858.CD008759.pub2.
3
Diagnostic performance of a new algorithm combining simple, non-invasive and inexpensive tests for predicting the presence of advanced liver fibrosis in patients with chronic hepatitis B.一种结合简单、无创且廉价检测方法的新算法对预测慢性乙型肝炎患者是否存在晚期肝纤维化的诊断性能。
BMC Gastroenterol. 2025 Jul 1;25(1):447. doi: 10.1186/s12876-025-03857-4.
4
Blood biomarkers for the non-invasive diagnosis of endometriosis.用于子宫内膜异位症无创诊断的血液生物标志物。
Cochrane Database Syst Rev. 2016 May 1;2016(5):CD012179. doi: 10.1002/14651858.CD012179.
5
Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients.肾移植和肾胰联合移植受者中BK多瘤病毒相关性肾病的血清和尿液核酸筛查试验
Cochrane Database Syst Rev. 2024 Nov 28;11(11):CD014839. doi: 10.1002/14651858.CD014839.pub2.
6
Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.疑似酒精性肝病患者肝纤维化无创诊断评估工具的系统评价和经济评估。
Health Technol Assess. 2012;16(4):1-174. doi: 10.3310/hta16040.
7
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
8
Vitamin D supplementation for chronic liver diseases in adults.成人慢性肝病的维生素D补充治疗
Cochrane Database Syst Rev. 2017 Nov 3;11(11):CD011564. doi: 10.1002/14651858.CD011564.pub2.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.肝细胞癌肝硬化监测:系统评价与经济分析
Health Technol Assess. 2007 Sep;11(34):1-206. doi: 10.3310/hta11340.

本文引用的文献

1
FIB-4 and APRI for cirrhosis detection in a privately insured national cohort.利用FIB-4和APRI在一个拥有私人保险的全国队列中检测肝硬化
JHEP Rep. 2023 Sep 30;6(1):100925. doi: 10.1016/j.jhepr.2023.100925. eCollection 2024 Jan.
2
Diagnosing the Stage of Hepatitis C Using Machine Learning.利用机器学习诊断丙型肝炎的阶段。
J Healthc Eng. 2021 Dec 10;2021:8062410. doi: 10.1155/2021/8062410. eCollection 2021.
3
Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C.
FIB-6的开发与多中心验证:一种用于排除慢性丙型肝炎患者肝硬化和代偿期晚期慢性肝病的新型机器学习简易床边评分系统
Hepatol Res. 2022 Feb;52(2):165-175. doi: 10.1111/hepr.13729. Epub 2021 Nov 24.
4
Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis.血小板计数作为慢性病毒性肝炎代偿期肝硬化的筛查工具。
World J Gastrointest Pathophysiol. 2021 May 22;12(3):40-50. doi: 10.4291/wjgp.v12.i3.40.
5
Dynamics of serum α-fetoprotein in viral hepatitis C without hepatocellular carcinoma.丙型病毒性肝炎无肝细胞癌患者血清甲胎蛋白的动态变化
Exp Ther Med. 2021 Jul;22(1):749. doi: 10.3892/etm.2021.10181. Epub 2021 May 12.
6
Validation of a machine learning approach using FIB-4 and APRI scores assessed by the metavir scoring system: A cohort study.基于 metavir 评分系统评估的 FIB-4 和 APRI 评分的机器学习方法验证:一项队列研究。
Arab J Gastroenterol. 2021 Jun;22(2):88-92. doi: 10.1016/j.ajg.2021.04.003. Epub 2021 May 10.
7
Involvement of Machine Learning Tools in Healthcare Decision Making.机器学习工具在医疗保健决策中的应用。
J Healthc Eng. 2021 Jan 27;2021:6679512. doi: 10.1155/2021/6679512. eCollection 2021.
8
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside.丙型肝炎病毒清除后的肝纤维化逆转:从基础到临床。
Gastroenterology. 2021 Apr;160(5):1502-1520.e1. doi: 10.1053/j.gastro.2020.09.065. Epub 2021 Jan 30.
9
EASL recommendations on treatment of hepatitis C: Final update of the series - Some issues.欧洲肝脏研究学会丙型肝炎治疗指南:系列最终更新——若干问题
J Hepatol. 2021 Feb;74(2):473-474. doi: 10.1016/j.jhep.2020.10.013. Epub 2020 Nov 19.
10
Assisting the Non-invasive Diagnosis of Liver Fibrosis Stages using Machine Learning Methods.使用机器学习方法辅助肝纤维化阶段的非侵入性诊断。
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:5382-5387. doi: 10.1109/EMBC44109.2020.9176542.